This filing details a Limited Power of Attorney granted by Gregory Hyde Williams, a director at Paymentus Holdings, Inc. (PAY), to Thomas C. Barnds. This appointment authorizes Barnds to act on Williams' behalf regarding securities transactions and filings with the SEC. This includes executing necessary forms such as S...

This filing details a Power of Attorney granted by Douglas J. Williamson, a director of Vistagen Therapeutics, Inc., to Nick B. Tressler and Shawn K. Singh. The attorneys-in-fact are authorized to act on Mr. Williamson's behalf regarding SEC filings, including preparing, executing, and submitting forms such as 3, 4, 5,...

This filing is an Exhibit 24, a Power of Attorney, for Travis Witteveen, Head of Products and Portfolio at Gen Digital Inc. The document, dated June 15, 2026, authorizes Bryan Ko, Whitney Clark, and Kathryn White to act as attorneys-in-fact. They are empowered to execute, deliver, and file Forms 3, 4, and 5, including ...

This filing details insider ownership for TOP Financial Group Ltd. Yang Junli, identified as a 10% owner, officer, and director, reports holdings through two entities: Zhong Yang Holdings (BVI) Limited and QUANTUM LEAP LIMITED. Yang Junli holds 10,000,000 Class B Ordinary Shares directly. Indirectly, through Zhong Yang...

This filing reports that Yap Chee Keong, a director at BioNexus Gene Lab Corp, has initially acquired 0 shares of common stock. The ownership is direct, and the report was filed on March 7, 2022....

This filing reports insider ownership information for TOP Financial Group Ltd. The reporting owner, Yuen Ka Fai, who is a Director & CEO of the company, has reported no securities owned as of March 18, 2026. The signature date was July 31, 2026. This is a Form 3 filing, which is an initial statement of beneficial owner...

This filing reports that Knight Therapeutics Inc. now directly owns 658,629 shares of common stock in 60 Degrees Pharmaceuticals, Inc. This represents a significant ownership stake, with Knight Therapeutics Inc. being identified as a ten percent owner. The transaction date was July 22, 2026. The filing was made on July...

This filing reports that David Natan, a director at Aterian, Inc. (ATED), has an initial statement of beneficial ownership. The filing indicates that Mr. Natan directly owns 0 shares of Common Stock following the transaction. Footnote F1 clarifies that no shares of Common Stock are beneficially owned, and the "noSecuri...

This SEC Form 3 filing reports that Avraham Ben-Tzvi, a director of Aterian, Inc. (ATER), has no beneficial ownership of the company's common stock as of July 17, 2026. The filing indicates that Ben-Tzvi owns 0 shares of Aterian common stock, with a footnote explicitly stating "No shares of Common Stock are beneficiall...

This SEC Form 3 filing reports that Avraham Ben-Tzvi, a director of Aterian, Inc. (ATER), has no beneficial ownership of the company's common stock as of July 17, 2026. The filing indicates that Ben-Tzvi owns 0 shares of Aterian common stock, with a footnote explicitly stating "No shares of Common Stock are beneficiall...

This filing is an Exhibit 24, a Power of Attorney granted by Christy J. Oliger, a director of Bicara Therapeutics Inc. (BCAX), to specific individuals within the company and its legal counsel. The attorneys-in-fact are authorized to execute and file various U.S. Securities and Exchange Commission (SEC) forms on behalf ...

This is a Form 3 filing indicating Dennis C. Schemm's appointment as a director of Blink Charging Co. (BLNK). The filing shows Schemm as a director (isDirector: 1) but not an officer or 10% owner. Notably, the "noSecuritiesOwned" field is set to 1, suggesting that at the time of filing, Schemm did not own any securitie...

This SEC Form 3 filing includes a Limited Power of Attorney granted by Chandrasekhar Thota, a director of Dynatrace, Inc. (NYSE: DT), to Nicole Fitzpatrick and Marc Gold. The power of attorney authorizes these individuals to execute various SEC filings on Thota's behalf, including Forms 3, 4, 5, Form 144, Schedules 13D...

This filing reports a change in beneficial ownership for Paul John Smith, a director at Humana Inc. (HUM). The report indicates that following a transaction, Mr. Smith now owns 0 shares of Humana Common stock. This is an initial filing (Form 3) detailing ownership changes for insiders....

This filing details the ownership of House of Doge Inc. (HODO) as of June 30, 2026. Sarosh Mistry, who is the Chief Executive Officer of Avenyr Capital LLC and a director of House of Doge Inc., indirectly holds 266,362 shares of common stock through Avenyr Capital LLC. These shares were acquired upon the closing of a M...

This filing reports initial ownership of securities by Michael C. Sullivan, Chief Commercial Officer of Illumina, Inc. (ILMN). The report, dated July 29, 2026, pertains to the period ending July 20, 2026. Mr. Sullivan, through Robert Maynes, has reported no securities owned as of the reporting date. The filing is a For...

This filing details a Power of Attorney granted by James Nelson Pepin, reporting owner, to Ephraim Hofsäß, Lorenzo Gerardi, and Mona Rinn. The attorneys-in-fact are authorized to maintain SEC EDGAR system credentials, execute and file Forms 3, 4, and 5 on behalf of Mr. Pepin in his capacity as a reporting person for Im...

This filing reports that Knight Therapeutics Inc. now directly owns 658,629 shares of common stock in 60 Degrees Pharmaceuticals, Inc. This represents a significant ownership stake, with Knight Therapeutics Inc. being identified as a ten percent owner. The transaction date was July 22, 2026. The filing was made on July...

This filing details the ownership of House of Doge Inc. (HODO) as of June 30, 2026. Sarosh Mistry, who is the Chief Executive Officer of Avenyr Capital LLC and a director of House of Doge Inc., indirectly holds 266,362 shares of common stock through Avenyr Capital LLC. These shares were acquired upon the closing of a M...

This filing reports that David Natan, a director at Aterian, Inc. (ATED), has an initial statement of beneficial ownership. The filing indicates that Mr. Natan directly owns 0 shares of Common Stock following the transaction. Footnote F1 clarifies that no shares of Common Stock are beneficially owned, and the "noSecuri...

This filing reports changes in beneficial ownership for Kristen J. Pederson, a director at NPK International Inc. The report indicates that Ms. Pederson has no direct securities ownership as of the reporting date, July 28, 2026. The filing is made in accordance with SEC reporting requirements for insiders. The signatur...

This is a Form 3 filing by Rajkumar V. Patil, Chief Scientific Officer of OKYO Pharma Ltd (ticker: OKYO), reporting his initial beneficial ownership in the company. The filing discloses Patil's direct holdings as of March 18, 2026, including both common stock and extensive option grants. Patil holds 16,667 shares of co...

This filing is an Exhibit 24, a Power of Attorney granted by Christy J. Oliger, a director of Bicara Therapeutics Inc. (BCAX), to specific individuals within the company and its legal counsel. The attorneys-in-fact are authorized to execute and file various U.S. Securities and Exchange Commission (SEC) forms on behalf ...

This is a Form 3 filing by Rajkumar V. Patil, Chief Scientific Officer of OKYO Pharma Ltd (ticker: OKYO), reporting his initial beneficial ownership in the company. The filing discloses Patil's direct holdings as of March 18, 2026, including both common stock and extensive option grants. Patil holds 16,667 shares of co...

This filing reports changes in beneficial ownership for Kristen J. Pederson, a director at NPK International Inc. The report indicates that Ms. Pederson has no direct securities ownership as of the reporting date, July 28, 2026. The filing is made in accordance with SEC reporting requirements for insiders. The signatur...